COVID-19 Patient Assistance Programs

Apr 30

Dexcom Patient Assistance Program for US Patients During the COVID-19 Pandemic

The Dexcom Patient Assistance Program (“Program”) will be available to current U.S. customers who have lost their health insurance coverage as a result of the impact of the COVID-19 pandemic.* The Program will launch in the next several weeks and will be available during the COVID-19 pandemic in the United States. For those existing U.S. customers who qualify for participation in Dexcom’s Program, Dexcom will offer:

Up to two shipments of 90-days of Dexcom continuous glucose monitoring (“CGM”) system supplies, with each shipment consisting of one transmitter and three boxes of three sensors
Reduce patient cost to $45 per 90-day supply shipment

*Patients that are eligible for coverage of their Dexcom CGM systems under a federal or state government program (such as Medicare, Medicaid or VA benefits) are not eligible to participate in this Program. Certain terms and conditions will apply to be eligible for participation in the Program, such as the submission of a complete Program application and documentation showing loss of healthcare benefits.

Learn more at https://www.dexcom.com/covid19-assistance

Omnipod Patient Assistance Program for US Patients During the COVID-19 Pandemic

Omnipod knows the economic downturn will affect many of our current Podders and we want to help them through this challenging time. As a result, we have expanded the benefits of our U.S. financial assistance program for our users who have been negatively impacted by COVID-19. Upon meeting certain financial criteria, a current Podder may receive up to a six-month supply of products free of charge. To learn more about this program, please call us at 1 (800) 591-3455 and select Option 2. A member of our team would be happy to discuss your situation and provide options.

The Omnipod Corona-19 page is at https://www.myomnipod.com/coronavirus